Concepedia

H Oshima

HO

Statistics

Publications

6

Citations

404

H-Index

6

Active since

1974

Affiliations

Sapporo Medical University(Current)

H Oshima is an author at Sapporo Medical University specializing in medicine, pharmacology, and cardiology.

ORCID

Publications per year

1974–2020

6

Publications

6

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts

Masashi Mizuno, Atsushi Kuno, Toshiyuki Yano et al. · Physiological Reports · 2018 · 168 citations · Full text

, , +9

Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats

H Oshima, Takayuki Miki, Atsushi Kuno et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 127 citations · Full text

, , +14

Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats

Atsushi Kuno, Yukishige Kimura, Masashi Mizuno et al. · Scientific Reports · 2020 · 37 citations · Full text

, , +15

Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes

Tatsuya Sato, H Oshima, Kei Nakata et al. · Journal of Diabetes Investigation · 2018 · 33 citations · Full text

, , +17

Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus

Kei Nakata, Takayuki Miki, Masaya Tanno et al. · PLoS ONE · 2017 · 23 citations · Full text

, , +14

1–5 of 6